Effects of drugs associated with hyperprolactinemia on plasma steroids and on steroid receptors and metabolism in human breast cancer R. C. MasonW. R. MillerA. P. M. Forrest Report Pages: 331 - 338
Interrupted pregnancy as an indicator of poor prognosis in T1, 2, N0, M0 primary breast cancer Helen E. OwnbySilvana MartinoThe Breast Cancer Prognostic Study Associates Report Pages: 339 - 344
Prognostic value of estrogen and progesterone receptors in primary breast cancer Simone SaezFrançoise CheixBernard Asselain Report Pages: 345 - 353
Relation of estrogen and/or progesterone receptor content of breast cancer to patient outcome following adjuvant chemotherapy Bernard FisherCarol K. Redmondother NSABP investigators Report Pages: 355 - 364
Chemoendocrine therapy vs chemotherapy alone for advanced breast cancer in postmenopausal women: Preliminary report of a randomized study Carl G. KardinalMichael C. PerryCancer and Leukemia Group B Report Pages: 365 - 371
Lack of efficacy of xeroradiography to preoperatively detect axillary lymph node metastases in breast cancer G. F. Coopmans de YoldiC. AndreoliA. Rasponi Report Pages: 373 - 376
Psychosocial and physical outcomes of primary breast cancer therapy: Mastectomy vs excisional biopsy and irradiation Wendy SchainBrenda K. EdwardsAllen S. Lichter Report Pages: 377 - 382
Plasminogen activator and progesterone receptor are correlated in human mammary tumors H. MagdelénatJ. BiethJ. C. Durand Correspondence Pages: 383 - 384